Androgenetic alopecia

Androgenetic alopecia, often shortened to AGA, is the most common form of progressive hair thinning in both men and women. The core issue is not an acute inflammatory event and not just a temporary vitamin shortage. It is a long-term sensitivity of hair follicles to androgens, especially dihydrotestosterone, together with a genetic tendency that makes some follicles progressively weaker over time. Because of this, the growth phase of the hair cycle becomes shorter, the shaft becomes thinner and less durable, and the follicle gradually miniaturizes. In practical terms, the person often notices reduced density, widening of the central part, thinning of the crown, recession of the frontal-temporal area, or the feeling that hair volume never truly comes back after shedding episodes. This is why AGA should be separated from temporary telogen shedding after stress, illness, childbirth, weight loss, or obvious nutrient depletion.

What happens to the follicles

The defining feature of androgenetic alopecia is gradual change rather than sudden disappearance of hair. With each cycle, the follicle may produce a shorter, finer, weaker hair. Healthy terminal hairs normally stay in an active growth phase for a relatively long time and maintain a meaningful shaft diameter. In AGA, the growth phase becomes shorter, miniaturized hairs increase, and the scalp starts to show through more clearly. In men this often appears as frontal recession and thinning on the vertex. In women it more often shows up as diffuse thinning across the top of the scalp and widening of the part line, usually without the classic male recession pattern. This visual pattern matters because it helps distinguish AGA from other causes of shedding where the problem may be iron deficiency, hypothyroidism, severe stress, post-infectious telogen effluvium, or inflammatory scalp disease.

Why androgens matter, but not in a simplistic way

AGA is often reduced to the idea that “testosterone causes hair loss,” but the real picture is more nuanced. The problem is not always a dramatically elevated androgen level in blood tests. A major role is played by local sensitivity of hair follicles and the activity of 5-alpha-reductase, the enzyme that converts testosterone into dihydrotestosterone. One person may have laboratory values in the normal range and still show clear AGA, while another with similar numbers may lose hair much more slowly. In women, the picture is often influenced further by polycystic ovary syndrome, insulin resistance, chronic stress, low protein intake, vitamin D deficiency, and iron depletion. These factors do not necessarily create AGA from nothing, but they can make the pattern more obvious and accelerate visible thinning.

How to distinguish AGA from other types of hair loss

For practical decision-making, it is important not to confuse androgenetic alopecia with telogen effluvium. After a viral infection, surgery, childbirth, severe stress, or abrupt caloric restriction, hair can shed diffusely and dramatically. That does not automatically mean AGA. In telogen effluvium, the complaint is often the sudden volume of shedding itself, while in AGA the bigger clue is progressive thinning and loss of density in a characteristic distribution. Another common mistake is to blame everything on nutrient deficiencies without examining the pattern of hair loss. Iron deficiency, low zinc, low selenium, poor protein intake, low B12, folate problems, and hypothyroidism can all worsen hair quality and increase shedding, but if the scalp pattern clearly points toward crown thinning or a widening part, correction of deficiencies alone may not fully stop the androgen-related process. Mixed cases also exist, and they are common enough to matter in real life.

What evaluation usually helps

When AGA is suspected, useful evaluation goes beyond simply counting shed hairs. Dermatoscopic examination may show miniaturization, variation in shaft diameter, and the typical pattern of affected follicles. On the laboratory side, ferritin, complete blood count, vitamin B12, folate, vitamin D, thyroid markers, and in some cases zinc, copper, glucose, and insulin can all be relevant. In women, androgen profile, prolactin, and signs of polycystic ovary syndrome may also matter depending on the history. The reason this broader workup is useful is that even when AGA is the main diagnosis, severity and progression are often amplified by systemic issues such as metabolic stress, poor sleep, insulin resistance, nutrient depletion, or endocrine instability.

What is usually discussed in treatment and support

Management depends on sex, age, severity, the speed of progression, and the presence of other causes of shedding. In ordinary practice, topical and systemic options may be considered to slow follicle miniaturization and support the growth phase. Nutritional and supplement-oriented support usually focuses on protein status and deficiency correction only when real deficits are present, rather than throwing a random mix of products at the problem. Ingredients that interact with the androgen pathway, such as saw palmetto, are also discussed in some protocols, but they should not be treated as instant cosmetic fixes or as guaranteed replacements for evidence-based medical treatment in more advanced cases. Another important practical point is timing: hair cycles are slow, so meaningful assessment usually takes months rather than a few weeks.

What makes the outlook worse

The worst pattern is often delay. People may spend a long time on shampoos, scalp massage, or random vitamins without ever clarifying whether the loss pattern is truly androgenetic. Repeated crash diets, chronic sleep loss, low protein intake, iron deficiency, uncontrolled insulin resistance, and persistent stress can all worsen the course. Once miniaturization is advanced, restoring previous density becomes much harder than slowing early decline. For that reason, AGA is best understood not as a trivial cosmetic annoyance but as a long-term biological process that benefits from early recognition, pattern-based diagnosis, and a patient, structured approach instead of a search for one miracle jar.